Mucoadhesive drug delivery systems interact with mucus and increase the residence time of dosage forms at the site of absorption. They are part of controlled delivery systems and can target drugs to specific sites, avoiding first-pass metabolism. The mechanisms of mucoadhesion involve contact and consolidation stages, where mucoadhesive molecules form bonds with mucus glycoproteins. Key factors that impact mucoadhesion include molecular weight, flexibility, crosslinking density, hydrogen bonding capacity, hydration, and polymer concentration. Common sites for these systems are the oral cavity, eye, vagina, nose, and gastrointestinal tract.